Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 18 May 2024

Time: 04:50

Research is the answer – the question is up to you

Professor to attend national researcher event

Story posted/last updated: 13 February 2019

On Tuesday 26 February 2019 at The Business Design Centre, Islington, London, The Brain Tumour Charity will host a unique opportunity to showcase their funded research as their Scientific Advisory Board (SAB) comes together from across the globe.

The event will unite those affected by brain tumours with world-leading medical experts

The panel, including Professor Colin Watts, Professor of Neurosurgery at the Queen Elizabeth Hospital Birmingham (QEHB) and Dr Susan Chang, Director of Neuro-Oncology at University of California, San Francisco, will be led by Professor Richard Gilbertson from the Cambridge Cancer Centre and also Chair of the Tessa Jowell Brain Cancer Mission.

Renowned researchers that are funded and scientific advisers to The Brain Tumour Charity, will present updates about innovative research in the brain tumour field together with a Q&A session to engage with those affected.

The SAB panel will be discussing the role of, symptom management, new therapies and developments and the progress made so far.

The floor will then be opened for the audience to ask about research, clinical trials, drug pathways, the Tessa Jowell BRAIN MATRIX trial and much more.

Jordan Toms, living with a brain tumour and one of The Charity’s Young Ambassadors: “It was so uplifting to be at the very first Ask the Researcher event in 2018, hearing the developments for our future care.

“And for the next one, I'm sure there will be more things to learn and even more ground breaking developments. I'd definitely recommend to anyone who's fighting or been affected by a brain tumour to go.

“No questions go unanswered, you will find a real sense of belonging at the event. Meeting people in similar circumstances.

“I know personally that the charity will have been working their upmost to give patients even more options and chances to defeat this terrible disease".

The evening will also tackle the questions of the areas of underfunded research and what are the biggest barriers to progress in the brain tumour field.

Dr David Jenkinson, The Brain tumour Charity’s Chief Scientific Officer says: “We know that those affected by a brain tumour have many questions about what is happening to ensure no-one else has to go through what they are experiencing.

“The evening will bring together a world-class group of researchers to discuss the progress research is making to bring hope to them and their families.”

“Every year, over 11,000 people are diagnosed with a brain tumour – that's 31 each and every day – and our five-year research strategy A Cure Can't Wait aims to double survival within ten years and halve the harm caused by brain tumours on quality of life."

“We are committed to fighting for all those people whose lives are turned upside down by this devastating disease.”

To find out more and book your place, please visit the The Brain Tumour Charity website.

Links

External websites will open in a new browser window.

University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.

Getting Here

Getting here

Information about travelling to, staying at and getting around the hospital.

Getting to the hospital

Jobs at UHB

Jobs at UHB

A great place to work. Learn why.

Jobs at UHB

news@UHB

news@UHB, the newsletter for patients, staff, visitors and volunteers at University Hospitals Birmingham NHS Foundation Trust

Read news@UHB

RSS

RSS feed

Subscribe to our news feed

View our RSS

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.